Biomarkers for Osteoporosis Management

Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion

(2010) Patrick Garnero et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro

(2010) Patrick Garnero et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis

(2010) Patrick Garnero et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Establishing a reference range for bone turnover markers in young, healthy women

(2008) S.J. Glover et al.   BONE

Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease

(2008) Ann E. Kearns et al.   ENDOCRINE REVIEWS

Effects of PTH and Alendronate on Type I Collagen Isomerization in Postmenopausal Women With Osteoporosis: The PaTH Study

(2008) Patrick Garnero et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures

(2007) Masataka Shiraki et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Serum Pentosidine Levels Are Positively Associated with the Presence of Vertebral Fractures in Postmenopausal Women with Type 2 Diabetes

(2007) Masahiro Yamamoto et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM